New hepatitis b drug enters human testing phase
NCT ID NCT06671093
Summary
This early-stage trial is testing a new drug called Tune-401 in adults with chronic hepatitis B. The main goal is to check if the drug is safe and how the body processes it. Researchers will also measure how it affects the hepatitis B virus in participants who are already taking standard antiviral medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
New Zealand Clinical Research
RECRUITINGAuckland, 1010, New Zealand
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
PMSI Republican Clinical Hospital "Timofei Mosneaga", Arensia Exploratory Medicine Phase I Unit
RECRUITINGChisinau, MD2025, Moldova
Contact
-
Queen Mary Hospital, University of Hong Kong
RECRUITINGHong Kong, Hong Kong
Contact
Contact
Conditions
Explore the condition pages connected to this study.